Can fasting glucose levels or post-breakfast glucose fluctuations predict the occurrence of nocturnal asymptomatic hypoglycemia in type 1 diabetic patients receiving basal-bolus insulin therapy with long-Acting insulin?

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Mitsuishi, Sumie ^a   Nishimura, Rimei ^a,b   Ando, Kiyotaka ^a   Tsujino, Daisuke ^a   Utsunomiya, Kazunori ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN DETEMIR; INSULIN GLARGINE; LONG ACTING INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; BOLUS INJECTION; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; DOSAGE SCHEDULE COMPARISON; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEAL; MORNING DOSAGE; NOCTURNAL HYPOGLYCEMIA; POSTPRANDIAL STATE; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION; DRUG EFFECTS; HYPOGLYCEMIA; METABOLISM;

ADULT; BLOOD GLUCOSE; BREAKFAST; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FASTING; FEMALE; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN, LONG-ACTING; MALE; POSTPRANDIAL PERIOD;

EID: 84955559018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144041     Document Type: Article

References (27)

1. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study. Lancet. 2010; 375:481-489. doi: 10.1016/S0140-6736(09)61969-3
2. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 12; 358:2545-2559. doi: 10.1056/NEJMoa0802743
3. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358:2560-2572. doi: 10.1056/NEJMoa0802987
4. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med. 2001; 161:1653-1659.
5. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, et al; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010; 363:1410-1418. doi: 10.1056/NEJMoa1003795
6. Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, et al. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care. 2014; 37:217-225. doi: 10.2337/dc13-0701
7. Chow E, Bernjak A, Williams S, Fawdry RA, Hibbert S, Freeman J,et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes. 2014; 63:1738-1747. doi: 10.2337/db13-0468
8. Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med. 1991; 8:49-58.
9. Weston PJ, Gill GV. Is undetected autonomic dysfunction responsible for sudden death in Type 1 diabetes mellitus? The 'dead in bed' syndrome revisited. Diabet Med. 1999; 16:626-631.
10. Robinson RT, Harris ND, Ireland RH, Macdonald IA, Heller SR. Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with Type 1 diabetes. Diabetologia. 2004; 47:312-315.
11. Suys B, Heuten S, De Wolf D, Verherstraeten M, de Beeck LO, Matthys D, et al. Glycemia and corrected QT interval prolongation in young type 1 diabetic patients: what is the relation? Diabetes Care. 2006; 29:427-429.
12. Kaufman FR, Austin J, Neinstein A, Jeng L, Halvorson M, Devoe DJ, et al. Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. J Pediatr. 2002; 141:625-630.
13. Woodward A, Weston P, Casson IF, Gill GV. Nocturnal hypoglycaemia in type 1 diabetes-frequency and predictive factors. QJM. 2009; 102:603-607. doi: 10.1093/qjmed/hcp082
14. Choudhary P, Davies C, Emery CJ, Heller SR. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact? Diabet Med. 2013; 30:914-917. doi: 10.1111/dme.12175
15. Somogyi M. Exacerbation of diabetes by excess insulin action. Am J Med. 1959; 26:169-191.
16. Perriello G, De Feo P, Torlone E, Calcinaro F, Ventura MM, Basta G, et al. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus. N Engl J Med. 1988; 319:1233-1239.
17. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-Term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993:30; 329:977-986.
18. The Diabetes Control and Complications Trial Research Group.Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care. 1995; 18:1415-1427.
19. The Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991; 90:450-459.
20. Diabetes Research in Children Network (DirecNet) Study Group. Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes. Pediatr Diabetes. 2007; 8:199-205.
21. Banarer S, Cryer PE. Sleep-related hypoglycemia-Associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes. 2003; 52:1195-1203.
22. Jones TW, Porter P, Sherwin RS, Davis EA, O'Leary P, Frazer F, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med. 1998; 338:1657-1662.
23. Heise T, Hermanski L, Nosek L, Feldman A, Rasmussen S, Haahr H. Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes. Diabetes Obes Metab. 2012; 14:859-864. doi: 10.1111/j.1463-1326.2012.01627.x
24. Høi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B. The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia. 2005; 48:2437-2438.
25. Wiltshire EJ, Newton K, McTavish L. Unrecognised hypoglycaemia in children and adolescents with type 1 diabetes using the continuous glucose monitoring system: prevalence and contributors. J Paediatr Child Health. 2006; 42:758-763.
26. Wentholt IM, Maran A, Masurel N, Heine RJ, Hoekstra JB, DeVries JH. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations. Diabet Med. 2007; 24:527-532.
27. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008; 31:1473-1478. doi: 10.2337/dc08-0545